Neoadjuvant Cisplatin, Gemcitabine, Sunitinib Malate + Radical Cystectomy for TCC
Status:
Terminated
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
This trial will investigate the activity of sunitinib combined with cisplatin and gemcitabine
followed by radical cystectomy in patients with Transitional Cell Carcinoma (TCC) of the
Bladder.